News and Media - Candesant Biomedical

Skip to content

Now Hiring

About
Pipeline
Technology
- Targeted Alkali Thermolysis (TAT)
Physicians
Quality of Life Impact
SweatTech^TM
- Hear from Experts
- Sign up for information
Investors
News and Media

Now Hiring

Now Hiring

About
Pipeline
Technology
- Targeted Alkali Thermolysis (TAT)
Physicians
Quality of Life Impact
SweatTech^TM
- Hear from Experts
- Sign up for information
Investors
News and Media

Now Hiring

News and Media

NEWS AND MEDIA

Latest News

FDA clears targeted alkali thermolysis product for hyperhidrosis treatment

FDA Clears New Underarm Sweat Control Patch

The FDA Just Approved a New Patch Treatment for Excessive Sweating

Don't sweat it: FDA OKs single-use sodium patch to curb excessive underarm perspiration

FDA Clears Brella SweatControl Patch for Reduced Primary Axillary Hyperhidrosis

FDA Clears First Patch to Treat Axillary Hyperhidrosis

Novel Single-Use Patch Shows Promise for Axillary Hyperhidrosis

Novel Single-Use Patch Shows Promise for Primary Axillary Hyperhidrosis

Pivotal Clinical SAHARA Study Shows Candesant Biomedical's Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

Targeted alkali thermolysis patch lessens sweating, disease severity in hyperhidrosis

This Innovative Patch Could Stop Your Excessive Underarm Sweat

December 19, 2022

Targeted alkali thermolysis patch effective, well tolerated in axillary hyperhidrosis

December 9, 2022

Candesant Biomedical Introduces New SweatTech Initiative at ASDS

October 6, 2022

View All Close

PRESS RELEASES

Candesant Biomedical Receives FDA Clearance of Brella™¹, the First and Only 3-Minute SweatControl Patch™, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

April 13, 2023

Pivotal Clinical SAHARA Study Shows Candesant Biomedical’s Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

March 18, 2023

Candesant Biomedical Announces Late-Breaking Oral Presentation of Pivotal Clinical Trial Data for its Investigational Patch to Reduce Excessive Underarm Sweating (Primary Axillary Hyperhidrosis) at the American Academy of Dermatology 2023 Annual Meeting

March 9, 2023

Candesant® Biomedical Announces Publication of Pilot Study Data on a Novel, Non-invasive Medical Device for the Reduction of Axillary Hyperhidrosis

November 29, 2022

Candesant® Biomedical Launches SweatTech™ Initiative to Educate on the Evolution of Treatments for Hyperhidrosis (Excessive Sweating)

October 7, 2022

View All Close

CLINICAL PUBLICATIONS

Late Breaker Abstract

March 18, 2023

Candesant® Biomedical Launches SweatTech™ Initiative to Educate on the Evolution of Treatments for Hyperhidrosis (Excessive Sweating)

October 7, 2022

View All Close

MEDIA KIT

LOGOS

FACT SHEETS

MEDIA CONTACT

For all media inquires,
please contact Suzanne Haber at s.haber@togorun.com

Main

Pipeline
About
Technology
Physicians
Quality of Life Impact
Investors
SweatTech^TM
News and Media
Now Hiring
Patents

Pipeline
About
Technology
Physicians
Quality of Life Impact
Investors
SweatTech^TM
News and Media
Now Hiring
Patents

About

Leadership
Company
Board of Directors

Leadership
Company
Board of Directors

Technology

Targeted Alkali Thermolysis (TAT)

Targeted Alkali Thermolysis (TAT)

Physicians

In Practice
Integration
Procedure

In Practice
Integration
Procedure

CONTACT

Customer Service:
223-NO-SWEAT
(223-667-9328)

Follow us

Linkedin Facebook Instagram Twitter Youtube

Search

Search

Copyright 2023 © All rights Reserved. Design by Clinically Media

We use first and third party cookies to obtain statistical information to personalize our website and provide you with a better experience. If you continue without changing your settings, this demonstrates your consent to receive all cookies or other tracking technologies on the Candesant Biomedical website for the purposes described in our Privacy Policy. Please know that you can change your cookie settings at any time in your browser settings..

Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT

Scroll to Top